Mirae Asset Global Investments Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,335 shares of ARWR stock, worth $207,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,335
Previous 4,121
29.46%
Holding current value
$207,904
Previous $52,000
61.54%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ARWR
# of Institutions
321Shares Held
99.5MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$611 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$605 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$413 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$248 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$204 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.12B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...